欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/H/0251/002
药品名称INFANRIXTETRA
活性成分
    • diphtheria toxoid, adsorbed 0.0 0
    • Polio virus type 1, inactivated 0.0 0
    • Polio virus type 2, inactivated 0.0 0
    • Polio virus type 3, inactivated 0.0 0
剂型Suspension for injection
上市许可持有人GSK
参考成员国 - 产品名称France (FR)
NL21433
互认成员国 - 产品名称
    • Spain (ES)
    • Ireland (IE)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
    • Slovakia (SK)
许可日期2006/10/09
最近更新日期2025/09/20
药物ATC编码
    • J07CA02 diphtheria-pertussis-poliomyelitis-tetanus
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Vaccine
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase